Smith & Nephew plc Stock Sao Paulo

Equities

S1NN34

BRS1NNBDR009

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 04:10:00 2024-06-07 pm EDT 5-day change 1st Jan Change
30 BRL +11.48% Intraday chart for Smith & Nephew plc +14.16% +14.11%
Sales 2024 * 5.81B 30.82B Sales 2025 * 6.12B 32.46B Capitalization 11.52B 61.04B
Net income 2024 * 527M 2.79B Net income 2025 * 691M 3.66B EV / Sales 2024 * 2.43 x
Net Debt 2024 * 2.61B 13.85B Net Debt 2025 * 2.3B 12.18B EV / Sales 2025 * 2.26 x
P/E ratio 2024 *
23.2 x
P/E ratio 2025 *
17.2 x
Employees 18,452
Yield 2024 *
2.86%
Yield 2025 *
3.22%
Free-Float 99.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+11.48%
1 week+14.16%
Current month+14.16%
1 month+20.19%
3 months+13.64%
6 months+20.68%
Current year+14.11%
More quotes
1 week
26.91
Extreme 26.91
30.00
1 month
25.54
Extreme 25.54
30.00
Current year
24.46
Extreme 24.46
30.00
1 year
22.50
Extreme 22.5
30.00
3 years
22.50
Extreme 22.5
30.45
5 years
22.50
Extreme 22.5
30.45
10 years
22.50
Extreme 22.5
30.45
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-03-31
Director of Finance/CFO 56 Nov. 30
Compliance Officer - 99-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-09-30
Director/Board Member 62 23-09-13
Chairman 63 23-04-25
More insiders
Date Price Change Volume
24-06-07 30 +11.48% 1
24-06-04 26.91 +2.40% 1

Delayed Quote Sao Paulo, June 07, 2024 at 04:10 pm EDT

More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13.21 USD
Average target price
16.45 USD
Spread / Average Target
+24.58%
Consensus